Mr. Dax Ng is the Chief Business Officer at Livingstone Health. He is responsible for developing the Group’s growth and investment strategy and policy, and provides strategic growth advisory and recommendations for the Group in consultation with the Board, advisers, partners and investors. He maintains key relationships as well as sources for opportunities for collaboration or investment.
Before joining the Group, Mr. Dax Ng held senior management and strategic executive positions in property development divisions and the banking and finance sector, specialising in business acquisition, wealth management, investment consultancy, and product development.
Mr. Dax Ng holds a Bachelor of Chemical Engineering from the University of New South Wales. He has undertaken graduate certification for digital healthcare, encompassing healthcare analytics, legal issues and risk management, and healthcare leadership. In 2020, he completed courses in Prescription Drug, Regulation, Cost, and Access from Harvard-X. Mr. Dax Ng also holds certifications in Private Equity on sourcing private equity deals and fundraising, conducting due diligence and exit strategies from the Singapore Management University (SMU) Financial Training Institute, as well as the Fintech future of commerce certificate at Massachusetts Institute of Technology.
Mr. Dax Ng is an active grassroots leader and an associate member of the Singapore Institute of Directors.
